Research Papers:

CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasion

Long Fan, Qingyi Zhu, Li Liu, Cuicui Zhu, Haojie Huang, Shan Lu and Ping Liu _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:53244-53261. https://doi.org/10.18632/oncotarget.18387

Metrics: PDF 1241 views  |   HTML 2094 views  |   ?  


Long Fan1,*, Qingyi Zhu2,*, Li Liu3, Cuicui Zhu1, Haojie Huang4, Shan Lu1 and Ping Liu1

1Jiangsu Province Key Laboratory for Molecular and Medicine Biotechnology, Life Science College, Nanjing Normal University, Nanjing, Jiangsu, China

2Department of Urology, Jiangsu Province Hospital of TCM, Nanjing, Jiangsu, China

3Laboratory of Molecular Biology, Jiangsu Province Hospital of TCM, Nanjing, Jiangsu, China

4Mayo Clinic Cancer Center, Mayo Clinic College of Medicine, Rochester, MN, USA

*These authors have contributed equally to this work

Correspondence to:

Ping Liu, email: 08201@njnu.edu.cn

Haojie Huang, email: huanghj86@gmail.com

Keywords: androgen, androgen receptor, chemokine, CXCL13, prostate cancer

Received: July 10, 2016     Accepted: May 09, 2017     Published: June 07, 2017


Androgen receptor (AR) is a key transcription factor playing a critical role in prostate cancer (PCa) initiation and progression. However, the molecular mechanisms of AR action in prostate cancer are not very clear. CXCL13, known as B cell attracting chemokine1 (BCA-1), is a member of CXC chemokine family and relevant to cancer metastasis. This study shows that CXCL13 is an androgen-responsive gene and involved in AR-induced PCa cell migration and invasion. In clinical specimens, expression of CXCL13 in PCa tissues is markedly higher than that in adjacent normal tissues. In cultures, expression of CXCL13 is up-regulated by androgen-AR axis at both mRNA and protein levels. Furthermore, Chip-Seq assay identifies canonical androgen responsive elements (ARE) at CXCL13 enhancer and dual-luciferase reporter assays reveals that the ARE is highly responsive to androgen while mutations of the ARE abolish the reporter activity. Additional chromatin immunoprecipitation (ChIP) assays also identify that the ARE presents androgen responsiveness. In addition, CXCL13 promotes G2/M phase transition by increasing Cyclin B1 levels in PCa cells. Functional studies demonstrate that reducing endogenous CXCL13 expression in LNCaP cells largely weakens androgen-AR axis induced cell migration and invasion. Taken together, our study implicates for the first time that CXCL13 is an AR target gene and involved in AR-mediated cell migration and invasion in primary PCa.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 18387